/

Other

/

Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc.

Verified Nov 2026

Other

·

United States flag

Foster City, California

·

Since 2018

Mirum Pharmaceuticals is a biopharmaceutical company headquartered in Foster City, California, founded in 2018. With 200–500 employees and estimated revenue of $500M–$1B, the company develops treatments for rare liver and genetic diseases. Its approved medications include LIVMARLI for Alagille syndrome, CHOLBAM for bile-acid synthesis disorders, and CTEXLI for cerebrotendinous xanthomatosis, with a clinical pipeline targeting conditions including primary sclerosing cholangitis and Fragile X syndrome.

Mirum Pharmaceuticals, Inc.

Verified Nov 2026

AT A GLANCE

Founded

2018

Headquarters

United States flag

Foster City, California

Employees

200-500

Ownership

Mirum Pharmaceuticals, Inc. at a glance

Revenue

$500M-1B

Est. band

Employees

200-500

Founded

2018

Headquarters

Foster City, California

Industries

Automotive

Electric Vehicles

Medical

Overview

Mirum Pharmaceuticals is a biopharmaceutical company headquartered in Foster City, California, founded in 2018. With 200–500 employees and estimated revenue of $500M–$1B, the company develops treatments for rare liver and genetic diseases. Its approved medications include LIVMARLI for Alagille syndrome, CHOLBAM for bile-acid synthesis disorders, and CTEXLI for cerebrotendinous xanthomatosis, with a clinical pipeline targeting conditions including primary sclerosing cholangitis and Fragile X syndrome.

At a glance

Attribute

Detail

Founded

2018

Headquarters

Foster City, California

Employees

200-500

Revenue

$500M-1B (estimated)

What Mirum Pharmaceuticals, Inc. makes

The company markets three FDA-approved medications for rare metabolic and genetic liver disorders and maintains a clinical-stage pipeline with several investigational medicines in development.

Latest developments

Company details

Mirum operates globally with team members in North America and Europe, serving patients with rare and life-threatening diseases through direct engagement with healthcare providers and clinical trial participation. Mirum Pharmaceuticals, Inc. was founded in 2018, has an estimated 200-500 employees, and is headquartered in Foster City, California.

Frequently asked questions

What does Mirum Pharmaceuticals, Inc. do?

Mirum Pharmaceuticals is a biopharmaceutical company headquartered in Foster City, California, founded in 2018. With 200–500 employees and estimated revenue of $500M–$1B, the company develops treatments for rare liver and genetic diseases. Its approved medications include LIVMARLI for Alagille syndrome, CHOLBAM for bile-acid synthesis disorders, and CTEXLI for cerebrotendinous xanthomatosis, with a clinical pipeline targeting conditions including primary sclerosing cholangitis and Fragile X syndrome.

Where is Mirum Pharmaceuticals, Inc. headquartered?

Mirum Pharmaceuticals, Inc. is headquartered in Foster City, California (950 Tower Lane, Foster City, California, 94404).

When was Mirum Pharmaceuticals, Inc. founded?

Mirum Pharmaceuticals, Inc. was founded in 2018.

How big is Mirum Pharmaceuticals, Inc.?

Mirum Pharmaceuticals, Inc. has an estimated 200-500 employees, with revenue in the $500M-1B range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Foster City, California (HQ)Headquarters · United States
Foster City, California (HQ)950 Tower Lane, Foster City, California, 94404, United StatesHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.